Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

20 Feb 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Acetazolamide Extended-Release Capsules, 500 mg. Further, the company has submitted its press release.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..